What did @catreaamcknight actually say?
Here's the honest answer: the transcript contains song lyrics, not health claims. The actual spoken content is a musical track with no medical information whatsoever. Every health claim in this post lives entirely in the caption, not in the creator's voice.
The caption states that "GLP-1 medication could help manage symptoms of PCOS" and directs viewers to Mochi Health with a $40 discount link. This is a paid partnership (the #mochipartner and #Ad hashtags confirm that). So we're fact-checking a sponsored caption, not a health explainer. That distinction matters, because the creator never actually explains the mechanism, the evidence, or the limitations. They just drop the claim and a promo code.
To be fair, the disclosure is there. The #Ad tag and #mochipartner are visible. That's more transparency than a lot of similar posts. But a disclosed ad is still an ad, and the health claim still needs scrutiny.
Does the science back this up?
Partially, yes, but with significant caveats that never make it into captions like this one. GLP-1 receptor agonists do show promise for PCOS, primarily because weight loss itself improves hormonal profiles in women with the condition, and GLP-1 drugs are effective weight loss agents.
A 2023 systematic review by Cena et al. in Nutrients found that GLP-1 receptor agonists reduced BMI, improved menstrual regularity, and lowered androgen levels in women with PCOS. A randomized controlled trial by Raun et al. examined liraglutide specifically and found improvements in reproductive hormone profiles. However, most studies are small, short-term, and conducted in women with obesity and PCOS together. The evidence base for lean PCOS patients is much thinner. GLP-1 drugs are not FDA-approved to treat PCOS. They're approved for type 2 diabetes and chronic weight management. Using them for PCOS is off-label, which isn't automatically wrong, but it's a detail that deserves mention.
What did they get wrong (or right)?
The caption's core claim is not wrong, but it is incomplete in ways that could mislead a vulnerable audience. Women with PCOS are disproportionately targeted by weight loss marketing, and many are already frustrated by years of dismissal from clinicians. A vague promise that a medication "could help manage symptoms" without specifying which symptoms, under what conditions, or for which patients is not useful health information.
What's missing: no mention that this is off-label use, no acknowledgment that results are largely tied to weight loss rather than a direct PCOS mechanism, no discussion of who is and isn't a candidate, and no note on side effects like nausea, vomiting, or the rare but serious risk of pancreatitis. The "before and after" framing in the hashtags layers weight-loss transformation culture onto a complex endocrine condition, which does real harm to how PCOS is understood publicly.
What they got right: GLP-1 medications genuinely do appear to help some women with PCOS manage certain symptoms, particularly menstrual irregularity and hyperandrogenism tied to excess weight. That's not fabricated.
What should you actually know?
If you have PCOS and you're curious about GLP-1 medications, here's what a conversation with an actual clinician should cover. First, not all PCOS presentations are the same. There are four phenotypes, and metabolic dysfunction is not present in all of them. Second, the benefits seen in studies are largely mediated by weight loss. That means the drug isn't directly fixing your hormones in some novel way. It's reducing insulin resistance and body weight, which then improves hormonal signaling. Third, GLP-1 drugs are not a standalone PCOS treatment. They don't replace metformin, lifestyle intervention, or hormonal therapy where those are indicated.
A 2022 review by Stefanaki et al. in the Journal of Clinical Medicine noted that while GLP-1 agonists show metabolic benefits in PCOS, the evidence is insufficient to establish them as a primary treatment. Any telehealth platform worth using should be telling you this, not just offering $40 off.
The bottom line on this post
This is a paid ad dressed up as a personal health moment. The claim is not fabricated, but it is stripped of every nuance that would make it actually useful to someone making a healthcare decision. The science on GLP-1 drugs and PCOS is real and evolving, but it is not settled enough to justify the certainty this caption implies. If you're considering this for PCOS specifically, push your prescriber on the evidence, ask about your phenotype, and do not let a promo code be the thing that tips your decision.